IBDEI2L9 ; ; 04-FEB-2020
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,41312,2)
 ;;=^5015570
 ;;^UTILITY(U,$J,358.3,41313,0)
 ;;=N11.9^^152^2034^4
 ;;^UTILITY(U,$J,358.3,41313,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,41313,1,3,0)
 ;;=3^Chronic Tubulo-Interstitial Nephritis,Unspec
 ;;^UTILITY(U,$J,358.3,41313,1,4,0)
 ;;=4^N11.9
 ;;^UTILITY(U,$J,358.3,41313,2)
 ;;=^5015574
 ;;^UTILITY(U,$J,358.3,41314,0)
 ;;=N30.91^^152^2034^5
 ;;^UTILITY(U,$J,358.3,41314,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,41314,1,3,0)
 ;;=3^Cystitis,Unspec w/ Hematuria
 ;;^UTILITY(U,$J,358.3,41314,1,4,0)
 ;;=4^N30.91
 ;;^UTILITY(U,$J,358.3,41314,2)
 ;;=^5015643
 ;;^UTILITY(U,$J,358.3,41315,0)
 ;;=N30.90^^152^2034^6
 ;;^UTILITY(U,$J,358.3,41315,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,41315,1,3,0)
 ;;=3^Cystitis,Unspec w/o Hematuria
 ;;^UTILITY(U,$J,358.3,41315,1,4,0)
 ;;=4^N30.90
 ;;^UTILITY(U,$J,358.3,41315,2)
 ;;=^5015642
 ;;^UTILITY(U,$J,358.3,41316,0)
 ;;=N28.84^^152^2034^7
 ;;^UTILITY(U,$J,358.3,41316,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,41316,1,3,0)
 ;;=3^Pyelitis Cystica
 ;;^UTILITY(U,$J,358.3,41316,1,4,0)
 ;;=4^N28.84
 ;;^UTILITY(U,$J,358.3,41316,2)
 ;;=^5015628
 ;;^UTILITY(U,$J,358.3,41317,0)
 ;;=N28.85^^152^2034^8
 ;;^UTILITY(U,$J,358.3,41317,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,41317,1,3,0)
 ;;=3^Pyeloureteritis Cystica
 ;;^UTILITY(U,$J,358.3,41317,1,4,0)
 ;;=4^N28.85
 ;;^UTILITY(U,$J,358.3,41317,2)
 ;;=^270372
 ;;^UTILITY(U,$J,358.3,41318,0)
 ;;=N15.1^^152^2034^9
 ;;^UTILITY(U,$J,358.3,41318,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,41318,1,3,0)
 ;;=3^Renal & Perinephric Abscess
 ;;^UTILITY(U,$J,358.3,41318,1,4,0)
 ;;=4^N15.1
 ;;^UTILITY(U,$J,358.3,41318,2)
 ;;=^270371
 ;;^UTILITY(U,$J,358.3,41319,0)
 ;;=N16.^^152^2034^10
 ;;^UTILITY(U,$J,358.3,41319,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,41319,1,3,0)
 ;;=3^Tubulo-Interstitial D/O in Diseases Classigied Elsewhere
 ;;^UTILITY(U,$J,358.3,41319,1,4,0)
 ;;=4^N16.
 ;;^UTILITY(U,$J,358.3,41319,2)
 ;;=^5015597
 ;;^UTILITY(U,$J,358.3,41320,0)
 ;;=N15.9^^152^2034^11
 ;;^UTILITY(U,$J,358.3,41320,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,41320,1,3,0)
 ;;=3^Tubulo-Interstitial Disease,Unspec
 ;;^UTILITY(U,$J,358.3,41320,1,4,0)
 ;;=4^N15.9
 ;;^UTILITY(U,$J,358.3,41320,2)
 ;;=^5015596
 ;;^UTILITY(U,$J,358.3,41321,0)
 ;;=N12.^^152^2034^12
 ;;^UTILITY(U,$J,358.3,41321,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,41321,1,3,0)
 ;;=3^Tubulo-Interstitial Nephritis,Not Spec as Acute or Chronic
 ;;^UTILITY(U,$J,358.3,41321,1,4,0)
 ;;=4^N12.
 ;;^UTILITY(U,$J,358.3,41321,2)
 ;;=^5015575
 ;;^UTILITY(U,$J,358.3,41322,0)
 ;;=N28.86^^152^2034^14
 ;;^UTILITY(U,$J,358.3,41322,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,41322,1,3,0)
 ;;=3^Ureteritis Cystica
 ;;^UTILITY(U,$J,358.3,41322,1,4,0)
 ;;=4^N28.86
 ;;^UTILITY(U,$J,358.3,41322,2)
 ;;=^5015629
 ;;^UTILITY(U,$J,358.3,41323,0)
 ;;=A08.0^^152^2035^6
 ;;^UTILITY(U,$J,358.3,41323,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,41323,1,3,0)
 ;;=3^Enteritis,Rotaviral
 ;;^UTILITY(U,$J,358.3,41323,1,4,0)
 ;;=4^A08.0
 ;;^UTILITY(U,$J,358.3,41323,2)
 ;;=^5000052
 ;;^UTILITY(U,$J,358.3,41324,0)
 ;;=A08.11^^152^2035^1
 ;;^UTILITY(U,$J,358.3,41324,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,41324,1,3,0)
 ;;=3^Acute Gastroenteropathy d/t Norwalk Agent
 ;;^UTILITY(U,$J,358.3,41324,1,4,0)
 ;;=4^A08.11
 ;;^UTILITY(U,$J,358.3,41324,2)
 ;;=^5000053
 ;;^UTILITY(U,$J,358.3,41325,0)
 ;;=A08.19^^152^2035^2
